Myrthue A - Search Results

1

Effect of calcitriol on prostate-specific antigen in vitro and in humans.

Beer TM, Garzotto M, Park B, Mori M, Myrthue A, Janeba N, Sauer D, Eilers K. Beer TM, et al. Among authors: myrthue a. Clin Cancer Res. 2006 May 1;12(9):2812-6. doi: 10.1158/1078-0432.CCR-05-2310. Clin Cancer Res. 2006. PMID: 16675575

2

Calcitriol in cancer treatment: from the lab to the clinic.

Beer TM, Myrthue A. Beer TM, et al. Among authors: myrthue a. Mol Cancer Ther. 2004 Mar;3(3):373-81. Mol Cancer Ther. 2004. PMID: 15026558 Review.

3

Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomy.

Beer TM, Myrthue A, Garzotto M, O'hara MF, Chin R, Lowe BA, Montalto MA, Corless CL, Henner WD. Beer TM, et al. Among authors: myrthue a. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2225-32. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598784 Clinical Trial.

4

Rationale for the development and current status of calcitriol in androgen-independent prostate cancer.

Beer TM, Myrthue A, Eilers KM. Beer TM, et al. Among authors: myrthue a. World J Urol. 2005 Feb;23(1):28-32. doi: 10.1007/s00345-004-0476-y. Epub 2005 Jan 25. World J Urol. 2005. PMID: 15668801 Review.

5

Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer.

Garzotto M, Myrthue A, Higano CS, Beer TM. Garzotto M, et al. Among authors: myrthue a. Urol Oncol. 2006 May-Jun;24(3):254-9. doi: 10.1016/j.urolonc.2005.11.034. Urol Oncol. 2006. PMID: 16678060 Clinical Trial.

6

Calcitriol in the treatment of prostate cancer.

Beer TM, Myrthue A. Beer TM, et al. Among authors: myrthue a. Anticancer Res. 2006 Jul-Aug;26(4A):2647-51. Anticancer Res. 2006. PMID: 16886675 Free article. Review.

7

The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.

Myrthue A, Rademacher BL, Pittsenbarger J, Kutyba-Brooks B, Gantner M, Qian DZ, Beer TM. Myrthue A, et al. Clin Cancer Res. 2008 Jun 1;14(11):3562-70. doi: 10.1158/1078-0432.CCR-07-4649. Clin Cancer Res. 2008. PMID: 18519790

8

ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21.

Geng H, Rademacher BL, Pittsenbarger J, Huang CY, Harvey CT, Lafortune MC, Myrthue A, Garzotto M, Nelson PS, Beer TM, Qian DZ. Geng H, et al. Among authors: myrthue a. Cancer Res. 2010 Apr 15;70(8):3239-48. doi: 10.1158/0008-5472.CAN-09-3186. Epub 2010 Apr 13. Cancer Res. 2010. PMID: 20388787 Free PMC article.

9

CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity.

Qian DZ, Rademacher BL, Pittsenbarger J, Huang CY, Myrthue A, Higano CS, Garzotto M, Nelson PS, Beer TM. Qian DZ, et al. Among authors: myrthue a. Prostate. 2010 Mar 1;70(4):433-42. doi: 10.1002/pros.21077. Prostate. 2010. PMID: 19866475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters